Cargando…
Relevance of BET Family Proteins in SARS-CoV-2 Infection
The recent pandemic we are experiencing caused by the coronavirus disease 2019 (COVID-19) has put the world’s population on the rack, with more than 191 million cases and more than 4.1 million deaths confirmed to date. This disease is caused by a new type of coronavirus, the severe acute respiratory...
Autores principales: | Lara-Ureña, Nieves, García-Domínguez, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391731/ https://www.ncbi.nlm.nih.gov/pubmed/34439792 http://dx.doi.org/10.3390/biom11081126 |
Ejemplares similares
-
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
por: Mills, Richard J., et al.
Publicado: (2021) -
Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022) -
Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2
por: Chen, Irene P., et al.
Publicado: (2022) -
Bromodomain and extraterminal (BET) protein inhibitor, apabetalone, reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro
por: Gilham, D, et al.
Publicado: (2021) -
Clinical relevance of SARS-CoV-2 infection in late pregnancy
por: Ruggiero, Marta, et al.
Publicado: (2021)